-
We are getting closer to the $1,000 genome. Their business though is not to sell the machines, but rather to “wholesale” the process, in other words they will sequence only and offer no interpretations, which would be done by another company they would supply the sequencing information to. ...
-
Not only do we see venture capital money here, also some big Pharma names. In a related story, Roche sees diagnostic machines and test kits as crucial to assessing and treating disease in the future and their risk profile has recognition of being one large investor in a growing area of drug research...
-
Software for genomics research, you could almost call this the medical records software of genomics and like medical records it is varied and comes in lots of flavors too. This is some of the software that analyzes the sequencing performed by the manufactures of the machines that do the sequencing...
-
How hot is genomics today? There are several manufacturers of the machines that will accomplish running our DNA, our complete DNA. I know to the average person this gets a little confusing, but the companies listed here are the companies that manufacture the machines that do the entire work...
-
No we do hold the monopoly on this technology in the US, and this article brings to light that genomics is a global concern and effort. BD Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations...
-
Three companies teaming together to create a DNA based test to determine which patients will benefit from selected drug treatments. The one for breast cancer is already available, so one more effort towards more information from the start and smarter clinical trials. BD NEW YORK (GenomeWeb...
-
One of the first kits on the market, as the article states the test can assess whether breast cancer patients would benefit from Genentech's Herceptin cancer drug. The website as of today asks that you contact a sales person for additional information. BD The test, which received...
-
For anyone in R and D needing resequencing services for analysis relative to genomic disease research, applications are being accepted for the grants, using the single molecule analysis technology provided by Helicos. BD NEW YORK (GenomeWeb News) Expression Analysis said today that it has...
-
This is a very small clinical trial of 12 individuals with cancer, and any related treatment plans are still quite a few miles away, but more work with personalized medicine in progress. BD This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment...
-
The race continues, firms with backing, but nothing on the market yet, and a while before a product will show up as research and development continue. A big chunk of change from Intel doesn't hurt matters either for Pacific Biosciences. VisiGen Biotechnologies is also entered in...